Elastography in Alcoholic Liver Disease: kPa Thresholds
Practical Conclusion
In the WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1, 2024, alcoholic liver disease is highlighted as a separate scenario for elastography interpretation. The main reason is that liver stiffness in ALD reflects not only collagen and architectural remodeling but also reversible components: alcoholic inflammation, edema, cholestasis, vascular congestion, and recent food intake. Therefore, a single kPa result should not automatically be translated into a fibrosis stage without assessing the activity of the process.
For the ultrasound diagnostician, the optimal formulation of the conclusion is: specify the method, median stiffness in kPa, measurement quality, probability category of cACLD, and list identified confounders. In biochemically active ALD, repeat elastography is preferred after clinical stabilization and alcohol abstinence.
kPa Thresholds in ALD
WFUMB 2024 recommends focusing on the clinical task. If the task is to identify compensated advanced chronic liver disease, cACLD categories are applied. If the task is to approximately correlate the result with the morphological stage, thresholds validated mainly for transient elastography are used.
| Task | VCTE Threshold | Interpretation |
|---|---|---|
| Exclusion of cACLD | <10 kPa | cACLD is unlikely in the absence of other signs of chronic liver disease |
| Intermediate Zone | 10–15 kPa | cACLD is possible; assessment of inflammation, platelets, signs of portal hypertension, and dynamics is needed |
| Confirmation of cACLD | >15 kPa | cACLD is highly likely if major causes of false elevation are excluded |
| Clinically Significant Portal Hypertension | ≥25 kPa | CSPH is likely in an appropriate clinical context |
| Significant Fibrosis | ≈7.5 kPa | Benchmark for ≥F2 in ALD; sensitive to inflammatory confounders |
| Advanced Fibrosis | ≈9.5 kPa | Benchmark for ≥F3 in ALD |
| Cirrhosis | ≈12.5 kPa | Benchmark for F4 in ALD; does not replace the assessment of portal hypertension and complications |
Why Thresholds in ALD Are Less Straightforward
In viral hepatitis or stable metabolic disease, stiffness is often closer to structural fibrosis. In ALD, the contribution of necroinflammation and edema can be significant. Active alcohol consumption and alcoholic hepatitis can increase kPa faster than fibrosis forms or regresses. In such a situation, stiffness is a marker of the severity of current liver damage, but not a pure measure of stage.
A practical error is to write cirrhosis just because the median exceeded the F4 threshold. More correctly: signs of increased stiffness corresponding to a high probability of cACLD or cirrhosis, with a caveat about possible overestimation against the background of ALD activity.
Confounders: What to Look for Before Interpretation
| Factor | Mechanism of Influence | How to Reflect in the Conclusion |
|---|---|---|
| Alcoholic Inflammation | Edema, infiltration, hepatocyte necrosis increase stiffness independently of fibrosis | Indicate that fibrosis staging is limited in active process |
| Cholestasis | Increases intrahepatic pressure and stiffness | Correlate with bilirubin, bile ducts, clinical presentation |
| Venous Congestion | Sinusoidal fullness increases resistance to shear wave | Assess inferior vena cava, hepatic veins, right heart chambers |
| Recent Food Intake | Postprandial hyperemia may increase LSM | Conduct study fasting according to local protocol |
| Technical Limitations | Obesity, narrow intercostal spaces, ascites, and incorrect ROI reduce reliability | Indicate measurement quality and limitations |
Ultrasound Physician's Algorithm
- Before Measurement: clarify method, probe or trial, study conditions, presence of ascites, pronounced steatosis, cholestasis, heart failure, and laboratory activity.
- During Study: avoid large vessels, bile structures, lesions, capsule, and artifact zones; measure in homogeneous parenchyma of the right lobe.
- After Measurement: interpret the median in kPa not as an absolute stage, but as a probability of cACLD, advanced fibrosis, or portal hypertension.
- In Case of Discrepancy: recommend repeat after stabilization or a second non-invasive test, rather than increasing the stage based on a single number.
How to Formulate a Conclusion
Example for low risk: Liver stiffness by VCTE 7.2 kPa. Values below the cACLD threshold; no signs of high probability of advanced chronic liver disease by elastography. Interpretation considering clinical-laboratory data.
Example for gray zone: Liver stiffness 12.8 kPa, corresponds to the intermediate zone 10–15 kPa for cACLD. Against the background of active alcoholic liver disease, LSM may be overestimated; correlation with biochemical activity and re-evaluation after stabilization is advisable.
Example for high risk: Liver stiffness 18.6 kPa, which is above the threshold of high probability of cACLD. In the absence of pronounced inflammation, cholestasis, and venous congestion, the data support advanced chronic liver disease; assessment of signs of portal hypertension is required.
VCTE, pSWE, and 2D-SWE: Threshold Transferability
The numbers in the table are most applicable to transient elastography. For point shear wave elastography and 2D-SWE, results are also expressed in kPa, but inter-device transferability is limited: different systems form the wave and ROI differently. Therefore, the protocol should specify the specific technology and not mechanically transfer VCTE thresholds to another device without local validation and manufacturer recommendations.
The Role of Multiparametric Ultrasound
WFUMB 2024 considers elastography as part of multiparametric liver ultrasound. In ALD, it is useful to simultaneously assess signs of steatosis, liver morphology, spleen, ascites, portal blood flow, and collaterals. Such a combination reduces the risk of erroneous interpretation of a single kPa value and helps distinguish fibrosis from active reversible damage.
When to Repeat the Study
Repeat elastography is especially important if high LSM is obtained against the background of recent alcohol consumption, clinical picture of alcoholic hepatitis, cholestasis, or circulatory decompensation. A decrease in stiffness over time after abstinence and normalization of inflammatory activity indicates a significant reversible component. Consistently high values, especially above 15 kPa, more strongly support cACLD; values around 25 kPa and above require the search for clinically significant portal hypertension.
Frequently asked questions
Can 12.5 kPa immediately indicate cirrhosis in alcoholic liver disease?
No. 12.5 kPa is a benchmark for F4 in ALD, but with active inflammation, cholestasis, or congestion, stiffness may be falsely elevated. It's better to indicate probability and confounders.
What is the main threshold for excluding advanced liver disease?
For cACLD according to WFUMB 2024, the key benchmark is <10 kPa: in the absence of other signs of advanced chronic liver disease, cACLD is unlikely.
Why might kPa decrease after alcohol abstinence?
The contribution of reversible components decreases: inflammation, edema, cholestatic and hemodynamic influence. This does not necessarily mean rapid fibrosis regression.